![](https://st1.latestly.com/wp-content/uploads/2024/08/ANI-20240801045157-588x441.jpg)
Business News | Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA
PRNewswire Singapore, August 1: Prestige Biopharma, a pioneer in biopharmaceuticals, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for Tuznue®, a …